Sat, Nov 29, 2014, 5:13 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Medgenics, Inc. Message Board

  • green_side_up green_side_up May 8, 2013 12:31 PM Flag

    Adding here...

    Stocks like MDGN are getting crushed in this stock market. Investors are buying dividend stocks. Story stocks like MDGN are not being bought...hence the low volume. This is when you add. MDGN reported solid Phase IIa results and expanded the number of indications for its biopump in the last month....all good news. Management and its investment banker really messed up back in 2012 by not doing an "at-the-money" stock offering. They were ill prepared. But, have since added a major financier to the Board, so that should help in terms of being smarter raising capital going forward.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • rxdavemull Jun 6, 2013 10:10 AM Flag

      Nice pickup at $4.00.No one is paying attention to MDGN.Now is the perfect time to pick up some shares.When no one is buying I like to pounce.

      Sentiment: Strong Buy

    • georgeclooney69696969 georgeclooney69696969 May 14, 2013 12:27 AM Flag

      I agree. The shares are an absolute steal at these prices. They have great Management, biomedical technology, and they have the funding albeit not using the best firm. It's just a matter of time now:).

    • Stop chasing dog poop! Look at KERX, CYTK, REGN, QCOR, THRX and RIGL if you want to play biopharma. MDGN is dead!!!! Look at my posts from last year. The lack capital and the dilution is going to be enormous to existing shareholders. Stay away!!!! THRX has plenty more to go.....REGN is way ahead of itself now but a great long term play!!!! See my posts! I've been in it for 5-years!!!! QCOR is an excellent value leverage play. It just started to breakout recently again. KERX already got good news this year but the best is yet to come. It will be a big time winner over the next 2 - 4 years!!! CYTK and RIGL are much more speculative but are working on some interesting stuff.

      Slow and steady! Good luck to all!

      • 3 Replies to argoalpuche
      • rxdavemull Aug 3, 2013 1:45 PM Flag

        Qcor was a no brainer since Acthar has a monopoly and is highly profitable.I also like KERX.MDGN will do fine with time like a great wine! Every stock has to have it's 3.00-$4.00 phase when no one notices.If there is no pumping at all and the stock is over $4.00 just imagine what will happen when Wall Street Cheatsheat,S/A,and Motley Fool begin to pump.It will be such a pretty sight to behold.

        Sentiment: Strong Buy

      • rxdavemull Jun 6, 2013 10:12 AM Flag

        I remember when KERX was $3.00 and no one wanted it.That was the time to buy.Same with THRX.Everyone notices after the stock has doubled.The trick is to buy when the stock is being bashed.

        Sentiment: Strong Buy

      • Sol Barer and Isaac Blech would not be involved if Medgenics was not a safe bet as there are plenty of bio firms that wuld love to have their support. There is a reason they have invested time and money in Medgenics unique delivery and protein production platform. It is a game changer and given time and money, MDGN will be huge. Patience and resiliency will prove this to be a winner. Don't take your eyes off the prize as short term dilutions and fund raise detour the stock prices. Time will tell who is right !

        Sentiment: Strong Buy

    • Thanks green-side ,
      Your comments make sense and should be considered by all who own MDGN. I have owned MDGN since last June then added more. My average is 8 , bummer, but I still like this biotech. I do believe that their science is worthy and will be ground breaking when in a more advanced stage. I would love to add more,when I can, but I still believe that,even if I can't , at some point my investment will more than double.
      Good luck all.

      Sentiment: Strong Buy

4.13-0.07(-1.67%)Nov 28 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.